+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotype and genotype in polycystic ovary syndrome



Phenotype and genotype in polycystic ovary syndrome



Recent Progress in Hormone Research 53: 217-256



Polycystic ovary syndrome (PCOS) is a common disorder in premenopausal women and is characterized by hyperandrogenic chronic anovulation. The cause is unknown. PCOS is associated with significant insulin resistance as well as with defects in insulin secretion. These abnormalities place these women at substantial risk for developing type 2 diabetes mellitus. A defect in insulin-mediated receptor autophosphorylation has been found in a substantial proportion of PCOS women. Both PCOS and the insulin resistance that accompanies it appear to have major genetic components. Family studies of PCOS have supported this, although they suffer from incomplete phenotyping of probands and first-degree relatives. The phenotype in males and nonreproductive age females is uncertain. Despite the shortcomings of the family studies of PCOS, they have consistently indicated familial clustering and suggested that the mode of inheritance is dominant. Our initial studies of 50 families of PCOS probands indicate that 24% of sisters are affected with PCOS. There also appears to be an intermediate phenotype of sisters with regular menstrual cycles who are hyperandrogenic per se (22% of sisters). Additionally, there appears to be a major familial defect, with 50% of first-degree relatives having glucose intolerance (impaired glucose tolerance by oral glucose tolerance test or type 2 diabetes mellitus). These findings suggest that hyperandrogenism in females and glucose intolerance may be genetic traits in PCOS kindreds. Systematic phenotyping will allow assignment of affected status for eventual linkage analysis.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973628

Download citation: RISBibTeXText

PMID: 9769710


Related references

Polycystic ovary syndrome. Phenotype to genotype. Endocrinology and Metabolism Clinics of North America 28(2): 379-396, 1999

Insulin resistance in polycystic ovary syndrome: Treating a phenotype without a genotype. Molecular & Cellular Endocrinology 145(1-2): 103-110, 1998

Insulin resistance in polycystic ovary syndrome: treating a phenotype without a genotype. Molecular and Cellular Endocrinology 145(1-2): 103-110, 1998

Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clinical Endocrinology 67(6): 917-922, 2007

Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome. Reproductive Sciences 21(8): 1034-1043, 2014

FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance. Plos one 5(12): E15303, 2010

Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome. European Journal of Endocrinology 166(4): 695-702, 2012

Polycystic ovary syndrome: A new phenotype in mosaic variegated aneuploidy syndrome?. Annales d'Endocrinologie 78(1): 58-61, 2017

Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome. Fertility and Sterility 102(3): 826-830, 2014

High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Gynecological Endocrinology 30(11): 781-784, 2014

Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial. Contemporary Clinical Trials 26(3): 271-280, 2005

There is no difference in the plasma cortisol level between women with body mass index (BMI) greater than or equal 25 kg/m² and polycystic ovary syndrome and the control group without polycystic ovary syndrome and BMI 25 kg/m². Przeglad Lekarski 73(4): 207-209, 2016

Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecological Endocrinology 22(2): 80-86, 2006

Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome--beyond ovulation induction. Human Reproduction 17(12): 3016-3026, 2002

Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome. Fertility and Sterility 92(4): 1372-1377, 2009